STATROL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Statrol, and when can generic versions of Statrol launch?
Statrol is a drug marketed by Alcon and is included in three NDAs.
The generic ingredient in STATROL is neomycin sulfate; polymyxin b sulfate. There are nineteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the neomycin sulfate; polymyxin b sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for STATROL?
- What are the global sales for STATROL?
- What is Average Wholesale Price for STATROL?
Summary for STATROL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 1 |
| DailyMed Link: | STATROL at DailyMed |
US Patents and Regulatory Information for STATROL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon | STATROL | neomycin sulfate; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 050344-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alcon | STATROL | neomycin sulfate; polymyxin b sulfate | SOLUTION/DROPS;OPHTHALMIC | 062339-001 | Nov 30, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alcon | STATROL | neomycin sulfate; polymyxin b sulfate | SOLUTION/DROPS;OPHTHALMIC | 050456-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
